These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3299078)

  • 21. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
    Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
    Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of the new H2-receptor antagonist mifentidine on gastric secretion, gastric emptying and experimental gastric and duodenal ulcers in the rat: comparison with cimetidine and ranitidine.
    Scarpignato C; Tangwa M; Tramacere R; Del Soldato P
    Digestion; 1986; 33(1):7-16. PubMed ID: 2866139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-dose intravenous H2 blocker prophylaxis against aspiration pneumonitis: assessment of drug concentration in gastric aspirate.
    Gonzalez ER; Kallar SK; Dunnavant BW
    AANA J; 1989 Jun; 57(3):238-43. PubMed ID: 2773628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study.
    Thorens J; Froehlich F; Schwizer W; Saraga E; Bille J; Gyr K; Duroux P; Nicolet M; Pignatelli B; Blum AL; Gonvers JJ; Fried M
    Gut; 1996 Jul; 39(1):54-9. PubMed ID: 8881809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness of cimetidine and ranitidine in peptic ulcer].
    Grigor'ev PIa; Kharkovskiĭ NN; Iakovenko EP; Prianishnikova AS; Soluianova IP
    Sov Med; 1986; (3):94-8. PubMed ID: 3520869
    [No Abstract]   [Full Text] [Related]  

  • 26. Bacterial genotoxicity of nitrosated famotidine.
    De Flora S; Camoirano A; Basso C; Astengo M; Zanacchi P; Bennicelli C
    Mutagenesis; 1986 Mar; 1(2):125-30. PubMed ID: 2905760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intragastric acidity, bacteria, nitrite, and N-nitroso compounds before, during, and after cimetidine treatment.
    Milton-Thompson GJ; Lightfoot NF; Ahmet Z; Hunt RH; Barnard J; Bavin PM; Brimblecombe RW; Darkin DW; Moore PJ; Viney N
    Lancet; 1982 May; 1(8281):1091-5. PubMed ID: 6122891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-nitroso compounds, genotoxins and their precursors in gastric juice from humans with and without precancerous lesions of the stomach.
    Pignatelli B; Malaveille C; Chen C; Hautefeuille A; Thuillier P; Muñoz N; Moulinier B; Berger F; De Montclos H; Ohshima H
    IARC Sci Publ; 1991; (105):172-7. PubMed ID: 1855844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental models for the biological detection of N-nitroso compounds formed from amines and nitrite.
    Baumeister M
    Toxicol Lett; 1982 Aug; 12(4):281-8. PubMed ID: 6753243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cimetidine, ranitidine, and their mutagenic nitroso derivatives.
    De Flora S
    Lancet; 1981 Oct; 2(8253):993-4. PubMed ID: 6117765
    [No Abstract]   [Full Text] [Related]  

  • 31. Histamine H2-receptor antagonists in the treatment of peptic ulcer disease.
    Wood JR; McIsaac RL
    S Afr Med J; 1988 Jul; 74 Suppl():51-4. PubMed ID: 3291155
    [No Abstract]   [Full Text] [Related]  

  • 32. Mutagenic activity of glycine upon nitrosation in the presence of chloride and human gastric juice: a possible role in gastric carcinogenesis.
    Gaspar J; Laires A; Va S; Pereira S; Mariano A; Quina M; Rueff J
    Teratog Carcinog Mutagen; 1996; 16(5):275-86. PubMed ID: 9122893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Famotidine in the therapy of gastric hypersecretory states.
    Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
    Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutagenicity studies on coffee. The influence of different factors on the mutagenic activity in the Salmonella/mammalian microsome assay.
    Friederich U; Hann D; Albertini S; Schlatter C; Würgler FE
    Mutat Res; 1985; 156(1-2):39-52. PubMed ID: 3889626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of H2-receptor antagonists in children.
    Dimand RJ
    DICP; 1990 Nov; 24(11 Suppl):S42-6. PubMed ID: 2270695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
    Del Soldato P; Ghiorzi A; Cereda E; Donetti A
    Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotoxicity of nitrosated ranitidine.
    Franekić J; Skupnjak S; Matijasević Z
    Mutat Res; 1989 Sep; 227(1):13-6. PubMed ID: 2671717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of gastric acid secretion in the dog by the H2-receptor antagonists, ranitidine, cimetidine, and metiamide.
    Daly MJ; Humphray JM; Stables R
    Gut; 1980 May; 21(5):408-12. PubMed ID: 6107261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Histamine H2-receptor antagonists as new anti-ulcer agents].
    Takemoto T
    Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
    [No Abstract]   [Full Text] [Related]  

  • 40. Cimetidine dynamics after repeated intravenous injection.
    Pancorbo S; Bubrick MP; Chin TW; Miller KW; Onstad G
    Clin Pharmacol Ther; 1984 Jan; 35(1):50-4. PubMed ID: 6690171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.